1858 — Beijing Chunlizhengda Medical Instruments Co Income Statement
0.000.00%
Last trade - 00:00
- HK$2.68bn
- HK$478.32m
- CNY1.21bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 855 | 938 | 1,108 | 1,202 | 1,209 |
Cost of Revenue | |||||
Gross Profit | 585 | 681 | 844 | 900 | 855 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 582 | 608 | 741 | 873 | 903 |
Operating Profit | 273 | 330 | 368 | 329 | 306 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 273 | 330 | 367 | 337 | 306 |
Provision for Income Taxes | |||||
Net Income After Taxes | 237 | 283 | 322 | 308 | 278 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 237 | 283 | 322 | 308 | 278 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 237 | 283 | 322 | 308 | 278 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.685 | 0.82 | 0.93 | 0.78 | 0.72 |
Dividends per Share |